Recipharm completes Blow-fill-seal expansion at Kaysersberg facility
Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a…
Browsing Category
Projects
Cambrex to expand its High Point, NC Facility
Cambrex Corporation announced that it is expanding its High Point, NC facility with the addition of a new $3.2 million, 11,000 sq. ft. analytical…
Hebron Technology wins design and implementation project Bid at Tianjin Chas esun
Hebron Technology won a bid on the design and implementation of an oil-free compressed air pipe project at a pharmaceutical production facility owned…
Takeda, Harrington to advance development of rare disease therapeutics
Takeda Pharmaceutical has entered into a multi-year partnership with Harrington Discovery Institute at University Hospitals in Cleveland, Ohio to…
Sutro Biopharma appoints Joseph M. Lobacki as Director
Sutro Biopharma Inc named Crestovo CEO and COO Joseph M. Lobacki to its board of directors.
Mr. Lobacki previously served as chief commercial…
Recipharm opens new GMP suite for clinical trial material
Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM)…
Amcor’s New On-Site Bottle Manufacturing Drives Efficiency and Sustainability at Campbell’s Plant
Amcor Rigid Plastics expands its relationship with long-time customer Campbell Soup Co. with the opening of an on-site bottle manufacturing operation…
UBP selects GE Flexfactory platform to new facility in Hsinchu Industrial park
Ge announced that United BioPharma Inc. (UBP) has selected GE Healthcare’s FlexFactory manufacturing platform for its new facility in Hsinchu…
Recipharm delivers first serialised batch to Saudi Arabia
Recipharm, the contract development and manufacturing organisation (CDMO), has delivered its first batch of serialised drug products to Saudi Arabia,…
ReForm Biologics Appoints John M. Sorvillo as CEO
ReForm Biologics, a pharmaceutical technology company that develops proprietary excipients to improve biologic formulations, announced that the…
Gerrit Dispersyn RXI pharmaceuticals NEW Chief Development Officer
RXi Pharmaceuticals announced that Gerrit Dispersyn, Dr. Med Sc. has been appointed as RXi's Chief Development Officer effective April 24, 2017.…
Grifols Donates 140 Million IU of Blood Clotting Factors to the WFH Humanitarian Aid Program
Grifols will donate a minimum of 140 million international units (IU) of blood clotting factor medicines (Factor VIII) to the World Federation of…
Transgene and Institut Bergonié Start the Phase 2 Part of the METROmaJX Trial
Transgene (Paris:TNG), a company that designs and develops viral-based immunotherapies announces that the first patient with soft tissue sarcoma (STS)…
Accenture and BioCelerate Join hands to Advance Biopharmaceutical Innovation
Accenture announced its collaboration with BioCelerate to Advance Biopharmaceutical Innovations through Increased Insights in Research &…
Catalent Expands Kansas City Clinical Storage & Secondary Packaging Capabilities
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer…
Sharp announces £9 million investment in European Clinical Services Centre of Excellence
Sharp Clinical Services (Sharp), part of UDG Healthcare plc has announced a £9 million investment to fund a new multiple-phase pharmaceutical…